Featured Research

from universities, journals, and other organizations

Role of enzyme TET2 in blood cell formation and cancer development

Date:
January 22, 2013
Source:
Centre for Genomic Regulation
Summary:
Researchers have described the way TET2 might act in the gene regulation of myeloid leukemia. The study was carried out by transforming one blood cell (B lymphocyte) into another (a macrophage), a process called transdifferentiation.

Researchers from the Centre for Genomic Research (CRG) have described the way TET2 might act in the gene regulation of myeloid leukemia. The study was carried out by transforming one blood cell (B lymphocyte) into another (a macrophage), a process called transdifferentiation.

"Learning how to induce transdifferentiation of cells with transcription factors allows us to understand the genetic instructions that defines a specialized cell type," says Eric Kallin, first author of the study.

One of the reasons for studying gene regulation through the transformation of one kind of cell into another is to maximize the changes that must occur to give rise to the resulting cellular fate. When progenitor cells are isolated and studied, a large number of specific factors are already expressed and this "primed" state can confound the full understanding of the lineage commitment process. However, using transdifferentiation (directly converting one cell into another through a technique developed by Thomas Graf, director of the CRG Gene Regulation, Stem Cells and Cancer programme and coordinator of this study), scientists can study the upregulation of fully repressed genes.

"We found that the enzyme TET2 is required to facilitate the activation of myeloid genes in our system. One hallmark of myelogenous leukemias is a block of terminal cell differentiation and the frequent mutation of TET2 that occurs in these diseases may contribute to this differentiation block," adds Kallin.

The next step is to discover how TET2 finds the genes that it activates and also how general this mechanism is in other types of cells.

The research was carried out thanks to funding from the Ministry of Science and Innovation, the AGAUR and the CONSOLIDER "Epigen้tica" project.


Story Source:

The above story is based on materials provided by Centre for Genomic Regulation. Note: Materials may be edited for content and length.


Journal Reference:

  1. Eric M. Kallin, Javier Rodrํguez-Ubreva, Jesper Christensen, Luisa Cimmino, Iannis Aifantis, Kristian Helin, Esteban Ballestar, Thomas Graf. Tet2 Facilitates the Derepression of Myeloid Target Genes during CEBPα-Induced Transdifferentiation of Pre-B Cells. Molecular Cell, 2012; 48 (2): 266 DOI: 10.1016/j.molcel.2012.08.007

Cite This Page:

Centre for Genomic Regulation. "Role of enzyme TET2 in blood cell formation and cancer development." ScienceDaily. ScienceDaily, 22 January 2013. <www.sciencedaily.com/releases/2013/01/130122122310.htm>.
Centre for Genomic Regulation. (2013, January 22). Role of enzyme TET2 in blood cell formation and cancer development. ScienceDaily. Retrieved August 2, 2014 from www.sciencedaily.com/releases/2013/01/130122122310.htm
Centre for Genomic Regulation. "Role of enzyme TET2 in blood cell formation and cancer development." ScienceDaily. www.sciencedaily.com/releases/2013/01/130122122310.htm (accessed August 2, 2014).

Share This




More Health & Medicine News

Saturday, August 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) — After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) — A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) — Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) — Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins